Flagship Pioneering Unveils Inzen Therapeutics; Company developing new class of transformative medicines based on Thanokine Biology
Jan 13, 2021 - PR Newswire
Board and Executive Moves-Product Launch
PR Newswire
Flagship Pioneering, a life science platforms company, today announced the unveiling of Inzen Therapeutics. Flagship created Inzen in 2017 to discover and develop a novel class of medicines based on a previously unrecognized area of biology that exerts broad and fundamental influence on cell state, discovered and named Thanokine™ Biology by Flagship's scientists. Flagship also announced the appointment of industry veteran Volker Herrmann, M.D., M.B.A. as the company's new...
Sign up today to gain access to 5 free articles a month from over 200 top subscription outlets.
Are you ready to take your business development to the next level with RelSci Professional?
Nurture your network with daily alerts that notify you when your relationships make news
Map your relationships to any target or prospect to identify a warm introduction
Access unlimited deep dossiers on over 8 million decision makers
Best of all, you can try out all these powerful business development tools absolutely free for 30 days!
Check out News Home to stay on top of the people and organizations you care most about.
